# Dr Lalchandani Labs Ltd (DLCL)
> Exchange: NSE | Sector: Healthcare | ISIN: 

## Price
Current Price: ₹9.67
Day Change: +4.99%
52W High: ₹28.7
52W Low: ₹8.87
Market Cap: ₹6 Cr

## Valuation
P/E: 12.56
P/B: 0.41
EPS: ₹0.77
Book Value: ₹23.42
Dividend Yield: 0%

## Returns
1Y Return: 0%

## Profitability
ROE: 0%
ROCE: 0%
Debt/Equity: 0
Revenue Growth: 0%
Profit Growth: 0%
EBITDA Margin: 0%
Operating Margin: 0%

## About
Dr Lalchandani Labs Ltd is a Diagnostics & Research company listed on BSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Healthcare
Industry: Diagnostics & Research
Sub Industry: Unknown

## Business Model
Overview: Dr Lalchandani Labs Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Diagnostics & Research. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Healthcare.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
- Announcement: Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
- BSE Filing: Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

## Access
Current tier: anonymous
More history: Register free to see 1 more year.

## Data Freshness
Quote Updated: 2026-05-17T00:32:45.816Z
Price History Updated: 2026-05-19T01:03:08.820Z
Latest Price History Date: 2026-05-15
Technicals Updated: 2026-05-19T01:03:08.820Z
Quant Updated: 2026-05-19T01:03:08.820Z
Sentiment Updated: 2026-05-19T01:03:08.820Z
Financials Status: current
Financials Updated: 2026-05-18T16:30:02.025Z
Financials Last Attempt: 2026-05-18T16:30:02.025Z
Financials Provider Tried: database
Latest P&L Period: FY 2025
Latest Balance Sheet Period: FY 2025
Latest Cash Flow Period: FY 2025

## P&L (FY 2022)
Revenue: ₹11 Cr
Operating Profit: ₹2 Cr (OPM 16.84%)
Net Profit: ₹1 Cr
Tax: ₹0 Cr

## Annual P&L History
FY 2022: Rev ₹11Cr | PAT ₹1Cr | OPM 16.84%
FY 2023: Rev ₹5Cr | PAT ₹-2Cr | OPM -8.74%
FY 2024: Rev ₹5Cr | PAT ₹1Cr | OPM -1.21%

## Balance Sheet (FY 2022)
Total Assets: ₹18 Cr
Total Liabilities: ₹8 Cr
Borrowings: ₹5 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

---
Source: rupiya.io/stocks/dlcl
Disclaimer: For research and education only. Not investment advice.